1. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis
   Xiao-Feng Xu et al, 2018, J Cell Biochem CrossRef
2. Fine‐mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women
   Mahalakshmi Kumaran et al, 2019, Int. J. Cancer CrossRef
3. Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer
   Yukimune Kanehira et al, 2019, Pharmaceutical Development and Technology CrossRef
4. Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer
   Yujing Li et al, 2019 CrossRef
5. A qualitative transcriptional signature for the early diagnosis of colorectal cancer
   Qingzhou Guan et al, 2019, Cancer Sci CrossRef
6. Dysregulation of Rho GTPases in Human Cancers
   Haiyoung Jung et al, 2020, Cancers CrossRef
7. miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10
   Zishu Wang et al, 2019, Mol Med Report CrossRef
8. ARHGAP24 regulates cell ability and apoptosis of colorectal cancer cells via the regulation of P53.
   Suiliang Zhang et al, 2018, Oncol Lett CrossRef
9. High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis
   Rui Bi et al, 2020, Aging CrossRef
10. RNA-seq analysis identifies cytoskeletal structural genes and pathways for meat quality in beef
    Joel D. Leal-Gutiérrez et al, 2020, PLoS ONE CrossRef
11. Current Study of RhoA and Associated Signaling Pathways in Gastric Cancer
    Haiping Liu et al, 2020, CSCR CrossRef
12. Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments
    Jingshu Wang et al, 2021, PLoS Genet CrossRef
13. ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway
    Lan-Lan Lin et al, 2021, Cancer Cell Int CrossRef
14. How can same-gene mutations promote both cancer and developmental disorders?
    Ruth Nussinov et al, 2022, Sci. Adv. CrossRef
15. miR-21-5p serves as a promoter in renal cell carcinoma progression through ARHGAP24 downregulation
    Bin Meng et al, 2022, Environ Sci Pollut Res CrossRef
16. Fixing the GAP: the role of RhoGAPs in cancer
    Gabriel Kreider-Letterman et al, 2022, European Journal of Cell Biology CrossRef
17. Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer
    Simona Del Giudice et al, 2022, Front. Cell Dev. Biol. CrossRef
18. Neurodevelopmental disorders, immunity, and cancer are connected
    Ruth Nussinov et al, 2022, iScience CrossRef
19. Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
    Shuqin Wang et al, 2022, Front. Oncol. CrossRef
20. Whole-genome sequencing reveals de-novo mutations associated with nonsyndromic cleft lip/palate
    Waheed Awotoye et al, 2022, Sci Rep CrossRef
21. Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?
    Huan Xiao et al, 2023, European Journal of Medicinal Chemistry CrossRef
22. Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK
    Ruth Nussinov et al, 2023, Biophys Rev CrossRef
23. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma
    Wenda Liu et al, 2023, BMC Cancer CrossRef
24. Loss of ARHGAP40 expression in basal cell carcinoma via CpG island hypermethylation
    Na Yu et al, 2023, Experimental Dermatology CrossRef
25. SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10
    Kui Wu et al, 2024, Cancer Reports CrossRef